VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Religa, Piotr ^a   Cao, Renhai ^a   Religa, Dorota ^a   Xue, Yuan ^a   Bogdanovic, Nenad ^a   Westaway, David ^b   Marti, Hugo H ^c   Winblad, Bengt ^a   Cao, Yihai ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A;

AGED; ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; CASE CONTROL STUDY; DISEASE MODEL; HUMAN; MEMORY DISORDERS; MIDDLE AGED; MOUSE; PATHOLOGY; VERY ELDERLY; ARTICLE; MEMORY DISORDER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; HUMANS; MEMORY DISORDERS; MICE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891709799     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02053     Document Type: Article

References (35)

1. Beckmann, N. et al. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23, 8453-8459 (2003).
2. Scholz, W. Studies on Pathology of the Brain Vessels II: The Glandular Degeneration of Brain Arteries and Capillaries. Z Neurol Psychiatr. 26, 694-715 (1938).
3. Vinters, H. V. & Gilbert, J. J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14, 924-928 (1983).
4. Mandybur, T. I. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25, 120-126 (1975).
5. Kim, J. H. et al. Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39, 339-345 (2006).
6. Meletis, K. & Frisen, J. Have the bloody cells gone to our heads? J Cell Biol 155, 699-702 (2001).
7. Mezey, E., and Chandross., K. J., Harta, G., Maki, R. A. & McKercher, S. R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779-1782 (2000).
8. Ferrara, N. & Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161, 851-858 (1989).
9. Gospodarowicz, D., Bialecki, H. & Greenburg, G. Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem 253, 3736-3743 (1978).
10. Udo, H. et al. Enhanced adult neurogenesis and angiogenesis and altered affective behaviors in mice overexpressing vascular endothelial growth factor 120. J Neurosci 28, 14522-14536 (2008).
11. Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20, 4368-4380 (2002).
12. Cao, Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2, re1 (2009).
13. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
14. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
15. Pucci, S., Mazzarelli, P., Missiroli, F., Regine, F. & Ricci, F. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon. Prog Brain Res 173, 555-573 (2008).
16. Kuhnert, F. et al. Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbetasignalingduring physiologicand tumor angiogenesis. Proc Natl Acad Sci U S A 105, 10185-10190 (2008).
17. Roskoski, R., Jr. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 375, 287-291 (2008).
18. Soker, S. Neuropilin in the midst of cell migration and retraction. Int J Biochem Cell Biol 33, 433-437 (2001).
19. Tessier-Lavigne, M. & Goodman, C. S. The molecular biology of axon guidance. Science 274, 1123-1133 (1996).
20. Carmeliet, P. & Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 436, 193-200 (2005).
21. Tessier-Lavigne, M., Placzek, M., and Lumsden., A. G., Dodd, J. & Jessell, T. M. Chemotropic guidance of developing axons in the mammalian central nervous system. Nature 336, 775-778 (1988).
22. Religa, D. et al. Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75 (2006).
23. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica 82, 239-259 (1991).
24. Religa, P. et al. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovascular research 65, 535-545, doi:10.1016/j.cardiores.2004.10.011 (2005).
25. Hyde, L. A. et al. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav Brain Res 160, 344-355 (2005).
26. Wang, Y. et al. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128, 52-63 (2005).
27. Vinters, H. V. et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18, 333-348 (1994).
28. Hansen, T. M., Moss, A. J. & Brindle, N. P. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res 5, 236-245 (2008).
29. Xue, Y. et al. Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proceedings of the National Academy of Sciences of the United States of America 105, 18513-18518, doi:10.1073/pnas.0807967105 (2008).
30. Vogel, J., Gehrig, M., Kuschinsky, W. & Marti, H. H. Massive inborn angiogenesis in the brain scarcely raises cerebral blood flow. J Cereb Blood Flow Metab 24, 849-859 (2004).
31. Cao, R. et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci U S A 96, 5728-5733 (1999).
32. Religa, P. et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106, 4184-4190, doi:10.1182/blood-2005-01-0226 (2005).
33. Religa, P. et al. Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1. PloS one 4, e4187, doi:10.1371/journal.pone.0004187 (2009).
34. Veitonmaki, N. et al. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb. Faseb J 17, 764-766 (2003).
35. El-Bakri, N. K. et al. Effects of estrogen and progesterone treatment on rat hippocampal NMDA receptors: relationship to Morris water maze performance. J Cell Mol Med 8, 537-544 (2004).